recording. We measured period and mean bioluminescence for each ROI with Chronostar V2.0 (a generous gift from A. Kramer, Charite, Berlin, Germany). All ROI periods ranged from 18 to 32 h. Mean period and bioluminescence were calculated from 101 ROIs per SCN slice.
Cannula Injections and Analysis
Prior to injection, all mice were entrained to 12:12 LD and released into constant darkness. Wheel-running behavior of the mice was monitored, and once the mutants' activity patterns had begun to fragment, estimated CT14 was calculated for each mouse and injections were carried out. Animals were allowed to free-run for 5-7 days after each injection, long enough to allow post-injection phase angle and period to be reliably calculated. Once most mutants' activity had become too fragmented for CT to reliably be calculated, the animals were re-entrained to 12:12 LD and re-released into DD. In practice, quantitative data could only be collected from behavior before and after the first injection in each round of entrainment and release into DD; rhythms were often too degraded to quantify period and, especially, phase in mutant animals after a second injection on the same round of entrainment. Over time, the mutants' behavioral phenotype worsened, and some mutants' rhythms broke down too quickly for CT to be reliably estimated. In these cases, arrhythmic mice were injected at the same solar time as the rhythmic mouse that had most closely tracked its CT in prior rounds of entrainment and release into DD.
Human prokineticin-2 isoform 2 (H-7342, Bachem, Torrance, CA) and porcine gastrin releasing peptide (H-1635, Bachem, Torrance, CA) were used in this study. The peptide was re-suspended in 0.9% sterile saline, aliquoted, and stored at -80C. Aliquots were thawed on ice no more than 1 h before the injection(s) for which they were used and stored on ice until immediately before use. 2 uL icv injections were given under dim red light using a syringe type microinjector (EW-07844-00, Gilmont, Libertyville, IL).
The mice were then left in DD for at least 5 days post-injection, and their wheel running behavior was analyzed as described in our Methods. After Prok2 injection, heteroscedastic two-tailed t-tests were used to analyze the significance of absolute phase and period changes in Excel. Since the mutants' rhythms were less robust than controls, their estimated CTs were less accurate. In cases where post-injection rhythms were robust enough to allow it, we calculated the true CT at the injection time post-hoc and computed its correlation with the injection effect by linear regression in Excel. After Grp injection, phase and period of mutant mice often became incalculable. Thus, instead of comparing period and phase shifts, animals of either genotype without calculable phase prior to injection were excluded, and the number of remaining mutant and control animals with calculable or incalculable phase post-injection were compared using a nonparametric 2x2 Fisher's exact test in GraphPad.
Generally, investigators performing circadian cannulation studies sample a range of circadian times and neuropeptide dosages during the course of the study. In our case, this was infeasible. Only ~30% of mutants had robust enough rhythms to be cannulated in the first place, and because the mice had to regularly be re-entrained and re-released into DD over the course of the study, each injection took well over a month to perform. Furthermore, the rhythms of even Lhx1-deficient mice with relatively mild behavioral phenotypes degraded with age, making it progressively more difficult to reliably determine the mutants' CTs as they aged. Due to these constraints, we chose to inject Prok2 at CT14 using a 114 uM injected peptide concentration, based upon the injection time and dosage shown to induce masking in a previous Prok2 icv cannulation study in wild-type rats (Cheng et al, 2002) . We chose to inject Grp at CT14 using a 114 uM injected peptide concentration based upon the injection time at which maximum phase shift occurs following Grp cannulation directly into hamster SCN (Piggins et al, 1995) and our calculation that this dosage would result in a CSF concentration of exogenous Grp well within the 100 nM to 10 uM concentration range of Grp shown to maximally shift the electrophysiological rhythms of rat SCN in culture (McArthur et al, 2000) . 
